GlassScriptPhysician profile
Mary Ann Tran
NPI 1770609620
$2,923.27
in general payments reported to CMS, 2019-2025
16 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 84% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.46 · 2023: $382 · 2024: $888 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,903.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,238.92 | 2022-2025 | Cabenuva, Apretude |
| Gilead Sciences, INC. | $569.05 | 2023-2025 | Biktarvy, Yeztugo |
| Abbvie INC. | $380.90 | 2023-2025 | Avycaz, Teflaro, Dalvance |
| Paratek Pharmaceuticals, INC. | $179.16 | 2024-2025 | Nuzyra |
| Glaxosmithkline, LLC. | $144.01 | 2025 | Arexvy, Nucala |
| Insmed, INC. | $141.01 | 2023-2025 | Arikayce |
| Lilly USA, LLC | $37.27 | 2025 | Zepbound |
| Viatris Specialty LLC | $33.15 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $31.67 | 2025 | Zerbaxa |
| Melinta Therapeutics, LLC | $30.55 | 2024 | Rezzayo, Kimyrsa |
| Theratechnologies INC. | $28.34 | 2025 | Egrifta, Trogarzo |
| United Therapeutics Corporation | $26.73 | 2025 | Tyvaso |
| Ani Pharmaceuticals, INC. | $25.45 | 2025 | Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $23.01 | 2025 | Dupixent |
| Harmony Biosciences LLC | $20.29 | 2023 | Wakix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2025 | Glassia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ann Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.